AlwhaibiAAlsaneaSAlmadiB, et al. (2022) Androgen deprivation therapy and depression in the prostate cancer patients: review of risk and pharmacological management. Aging Male25: 101-124.
2.
AntonucciSDi SanteMTonoloF, et al. (2021) The Determining Role of Mitochondrial Reactive Oxygen Species Generation and Monoamine Oxidase Activity in Doxorubicin-Induced Cardiotoxicity. Antioxid Redox Signal34: 531-550.
3.
BrunckhorstOHashemiSMartinA, et al. (2021) Depression, anxiety, and suicidality in patients with prostate cancer: a systematic review and meta-analysis of observational studies. Prostate Cancer Prostatic Dis24: 281-289.
4.
BurkeNNKerrDMMoriartyO, et al. (2014) Minocycline modulates neuropathic pain behaviour and cortical M1-M2 microglial gene expression in a rat model of depression. Brain Behav Immun42: 147-156.
5.
DineshAAHelena Pagani Soares PintoSBrunckhorstO, et al. (2021) Anxiety, depression and urological cancer outcomes: A systematic review. Urol Oncol39: 816-828.
6.
FervahaGIzardJPTrippDA, et al. (2019) Depression and prostate cancer: A focused review for the clinician. Urol Oncol37: 282-288.
7.
FlamandVZhaoHPeehlDM. (2010) Targeting monoamine oxidase A in advanced prostate cancer. J Cancer Res Clin Oncol136: 1761-1771.
8.
GaurSGrossMELiaoCP, et al. (2019) Effect of Monoamine oxidase A (MAOA) inhibitors on androgen-sensitive and castration-resistant prostate cancer cells. Prostate79: 667-677.
9.
GordonRRWuMHuangCY, et al. (2014) Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes. PLoS One9: e104271.
10.
GrossMEAgusDBDorffTB, et al. (2021) Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer. Prostate Cancer Prostatic Dis24: 61-68.
11.
HajizadehFOkoyeIEsmailyM, et al. (2019) Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells. Life Sci237: 116952.
12.
HeydendaelWJacobsonL. (2008) Differential effects of imipramine and phenelzine on corticosteroid receptor gene expression in mouse brain: potential relevance to antidepressant response. Brain Res1238: 93-107.
13.
HeydendaelWJacobsonL. (2010) Widespread hypothalamic-pituitary-adrenocortical axis-relevant and mood-relevant effects of chronic fluoxetine treatment on glucocorticoid receptor gene expression in mice. Eur J Neurosci31: 892-902.
14.
ChenCVBrummetJLLonsteinJS, et al. (2014) New knockout model confirms a role for androgen receptors in regulating anxiety-like behaviors and HPA response in mice. Horm Behav65: 211-218.
15.
ItsumiMShiotaMSekinoY, et al. (2020) High-throughput screen identifies 5-HT receptor as a modulator of AR and a therapeutic target for prostate cancer. Prostate80: 885-894.
KassiEMoutsatsouP. (2011) Glucocorticoid receptor signaling and prostate cancer. Cancer Lett302: 1-10.
18.
KierAHanJJacobsonL. (2005) Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression. Endocrinology146: 1338-1347.
19.
KumarR. (2020) Emerging role of glucocorticoid receptor in castration resistant prostate cancer: A potential therapeutic target. J Cancer11: 696-701.
20.
LapierreJAGearyLAJangJK, et al. (2022) Deletion of monoamine oxidase A in a prostate cancer model enhances anti-tumor immunity through reduced immune suppression. Biochem Biophys Res Commun634: 100-107.
21.
LeeHTChoiMRDohMS, et al. (2013) Effects of the monoamine oxidase inhibitors pargyline and tranylcypromine on cellular proliferation in human prostate cancer cells. Oncol Rep30: 1587-1592.
22.
LiYCWangLLPeiYY, et al. (2015) Baicalin decreases SGK1 expression in the hippocampus and reverses depressive-like behaviors induced by corticosterone. Neuroscience311: 130-137.
23.
LiaoCPLinTPLiPC, et al. (2018) Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate. Oncogene37: 5175-5190.
24.
LinPHLiuJMHsuRJ, et al. (2018) Depression Negatively Impacts Survival of Patients with Metastatic Prostate Cancer. Int J Environ Res Public Health15.
25.
MeenuMVermaVKSethA, et al. (2020) Association of Monoamine Oxidase A with Tumor Burden and Castration Resistance in Prostate Cancer. Curr Ther Res Clin Exp93: 100610.
26.
MiocinovicRMcCabeNPKeckRW, et al. (2005) In vivo and in vitro effect of baicalein on human prostate cancer cells. Int J Oncol26: 241-246.
27.
MollJMHoflandJTeubelWJ, et al. (2022) Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling. Prostate82: 505-516.
28.
OuXMChenKShihJC. (2006) Glucocorticoid and androgen activation of monoamine oxidase A is regulated differently by R1 and Sp1. J Biol Chem281: 21512-21525.
29.
PintoFDibitettoFRagoneseM, et al. (2022) Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives. Med Sci (Basel)10.
30.
PrasadSMEggenerSELipsitzSR, et al. (2014) Effect of depression on diagnosis, treatment, and mortality of men with clinically localized prostate cancer. J Clin Oncol32: 2471-2478.
31.
PuhrMEigentlerAHandleF, et al. (2021) Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer. Oncogene40: 3087-3100.
32.
RestaJSantinYRoumiguieM, et al. (2022) Monoamine Oxidase Inhibitors Prevent Glucose-Dependent Energy Production, Proliferation and Migration of Bladder Carcinoma Cells. Int J Mol Sci23.
33.
RomerBLewickaSKopfD, et al. (2009) Cortisol metabolism in depressed patients and healthy controls. Neuroendocrinology90: 301-306.
34.
SamanDMLemieuxAMNawal LutfiyyaM, et al. (2014) A review of the current epidemiology and treatment options for prostate cancer. Dis Mon60: 150-154.
35.
ShihJC. (2018) Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy. J Neural Transm (Vienna)125: 1553-1566.
36.
ShinkaTOnoderaDTanakaT, et al. (2011) Serotonin synthesis and metabolism-related molecules in a human prostate cancer cell line. Oncol Lett2: 211-215.
37.
ShulmanKIHerrmannNWalkerSE. (2013) Current place of monoamine oxidase inhibitors in the treatment of depression. CNS Drugs27: 789-797.
38.
TseilikmanVDremencovETseilikmanO, et al. (2020) Role of glucocorticoid- and monoamine-metabolizing enzymes in stress-related psychopathological processes. Stress23: 1-12.
39.
Van den EyndeVAbdelmoeminWRAbrahamMM, et al. (2022) The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. CNS Spectr: 1-14.
40.
WangKLuoJYehS, et al. (2020) The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer. Nat Commun11: 2689.
41.
WestabyDFenor de La MazaMLDPaschalisA, et al. (2022) A New Old Target: Androgen Receptor Signaling and Advanced Prostate Cancer. Annu Rev Pharmacol Toxicol62: 131-153.
42.
WuJBShaoCLiX, et al. (2014) Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis. J Clin Invest124: 2891-2908.
43.
ZhangCZhangYPLiYY, et al. (2019) Minocycline ameliorates depressive behaviors and neuro-immune dysfunction induced by chronic unpredictable mild stress in the rat. Behav Brain Res356: 348-357.
44.
ZhuWMaSQuR, et al. (2006) Antidepressant effect of baicalin extracted from the root of Scutellaria baicalensis. in mice and rats. Pharmaceutical biology44: 503-510.
